Correlation Between Neuropace and Modular Medical
Can any of the company-specific risk be diversified away by investing in both Neuropace and Modular Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Modular Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Modular Medical, you can compare the effects of market volatilities on Neuropace and Modular Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Modular Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Modular Medical.
Diversification Opportunities for Neuropace and Modular Medical
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neuropace and Modular is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Modular Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Modular Medical and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Modular Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Modular Medical has no effect on the direction of Neuropace i.e., Neuropace and Modular Medical go up and down completely randomly.
Pair Corralation between Neuropace and Modular Medical
Given the investment horizon of 90 days Neuropace is expected to under-perform the Modular Medical. In addition to that, Neuropace is 1.19 times more volatile than Modular Medical. It trades about -0.09 of its total potential returns per unit of risk. Modular Medical is currently generating about -0.09 per unit of volatility. If you would invest 102.00 in Modular Medical on May 10, 2025 and sell it today you would lose (27.00) from holding Modular Medical or give up 26.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Modular Medical
Performance |
Timeline |
Neuropace |
Modular Medical |
Neuropace and Modular Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Modular Medical
The main advantage of trading using opposite Neuropace and Modular Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Modular Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Modular Medical will offset losses from the drop in Modular Medical's long position.Neuropace vs. LivaNova PLC | Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics |
Modular Medical vs. CapsoVision, Common Stock | Modular Medical vs. Edwards Lifesciences Corp | Modular Medical vs. Outset Medical | Modular Medical vs. Venus Concept |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |